Current status of nanomaterial-based treatment for hepatocellular carcinoma

被引:90
作者
Baig, Badriya [1 ]
Halim, Sulafa Abdel [2 ]
Farrukh, Aaminah [1 ]
Greish, Yaser [2 ]
Amin, Amr [1 ]
机构
[1] UAE Univ, Dept Biol, Al Ain, U Arab Emirates
[2] UAE Univ, Dept Chem, Al Ain, U Arab Emirates
关键词
Hepatic carcinoma; Nanoparticles; Synthetic nanoparticles; Natural nanoparticles; Surface functionalization; MESOPOROUS SILICA NANOPARTICLES; SERUM-ALBUMIN NANOPARTICLES; IRON-OXIDE NANOPARTICLES; NANO-ANTIOXIDANT THERAPY; DRUG-DELIVERY SYSTEM; CARBON NANOTUBES; POLYMERIC NANOPARTICLES; LIPOSOMAL DOXORUBICIN; SILVER NANOPARTICLES; CANCER-DIAGNOSIS;
D O I
10.1016/j.biopha.2019.108852
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma (HCC), a prominent form of liver cancer, is the second leading cause of cancer-related deaths, thanks to the lack of efficient diagnostic tools and consequently late diagnosis and to the scarce of available suitable treatments. Thus, novel approaches to treat HCC are in demand. The fast-growing field of nanotechnology offers infinite possibilities to design materials in the nanoscale with unique properties due to their high surface area and small size. Nanotechnology enabled scientists to design drug delivery systems that serve multiple purposes including treatment, diagnostics and imaging. This review provides an update on the overall concept and potential of cancer nanotechnology; highlights the advances made particularly toward therapeutic nanomaterials targeting HCC. Obstacles hindering further development of nanomaterials -mediated cancer therapy will also be discussed.
引用
收藏
页数:12
相关论文
共 140 条
[1]   Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line [J].
Ahmadian, Elham ;
Dizaj, Solmaz Maleki ;
Rahimpour, Elaheh ;
Hasanzadeh, Amir ;
Eftekhari, Aziz ;
Zadegan, Hasan Hosain ;
Halajzadeh, Jamal ;
Ahmadian, Hale .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2018, 93 :465-471
[2]  
Al-Hrout A, 2017, BIOTECHNOLOGY AND PRODUCTION OF ANTI-CANCER COMPOUNDS, P73, DOI 10.1007/978-3-319-53880-8_3
[3]   Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds [J].
Amin, A. R. M. Ruhul ;
Karpowicz, Phillip A. ;
Carey, Thomas E. ;
Arbiser, Jack ;
Nahta, Rita ;
Chen, Zhuo G. ;
Dong, Jin-Tang ;
Kucuk, Omer ;
Khan, Gazala N. ;
Huang, Gloria S. ;
Mi, Shijun ;
Lee, Ho-Young ;
Reichrath, Joerg ;
Honoki, Kanya ;
Georgakilas, Alexandros G. ;
Amedei, Amedeo ;
Amin, Amr ;
Helferich, Bill ;
Boosani, Chandra S. ;
Ciriolo, Maria Rosa ;
Chen, Sophie ;
Mohammed, Sulma I. ;
Azmis, Asfar S. ;
Keith, W. Nicol ;
Bhakta, Dipita ;
Halicka, Dorota ;
Niccolai, Elena ;
Fujii, Hiromasa ;
Aquilano, Katia ;
Ashraf, S. Salman ;
Nowsheen, Somaira ;
Yang, Xujuan ;
Bilsland, Alan ;
Shin, Dong M. .
SEMINARS IN CANCER BIOLOGY, 2015, 35 :S55-S77
[4]   Ketoconazole-induced testicular damage in rats reduced by Gentiana extract [J].
Amin, Amr .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2008, 59 (06) :377-384
[5]   Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells [J].
Anirudhan, Thayyath Sreenivasan ;
Binusreejayan .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 88 :222-235
[6]  
[Anonymous], 2014, APPL NANOTECHNOLOGY, DOI DOI 10.5772/58673
[7]  
[Anonymous], 2009, BIOMETRICAL J
[8]  
[Anonymous], SEMINARS CANC BIOL
[9]  
[Anonymous], ADV THERAP
[10]  
[Anonymous], INT J DRUG DEV RES